尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Buckheit Robert, Cadre. Insider active across 1 company, notably Cytocom, Inc.. In total, 1 disclosures have been logged. Activity tracked since 27 July 2021. The latest transaction was filed on 27 July 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Robert Buckheit is Chief Technology Officer at Cytocom, Inc. In this role, he is responsible for managing technology and innovation within the company. Buckheit plays a key role in developing new technological solutions and optimizing operational processes. His expertise in technology is essential for Cytocom's success.